The Healthcare sector appears well positioned to outperform over the medium term, underpinned by three key dynamics: 1) highly attractive valuations, 2) attractive earnings growth, 3) and compelling bottom-up stock stories. In this report, we provide updated insights on the sector from a bottom-up perspective, focusing on ResMed, Telix Pharmaceuticals, CSL, and Cochlear.